Top in allergy/asthma: Epinephrine autoinjectors in schools; food allergy misconceptions
Click Here to Manage Email Alerts
A law moving through California’s legislature would require schools to store epinephrine autoinjectors in accessible locations and broadly share where those are, enabling prompt responses when children have anaphylactic reactions.
“Time is of the essence. If people cannot find those epinephrine autoinjectors, that can lead to a fatality,” Jason Linde, MA, senior vice president of government and community affairs with Food Allergy Research & Education, told Healio, adding that the law seeks “a small but important change.”
It was the top story in allergy/asthma last week.
Another top story was the latest installment of Healio’s “Food Allergy: Fact vs. Fiction” column, in which Douglas H. Jones, MD, explores common misconceptions around food allergies, intolerances and sensitivities.
Read these and more top stories in allergy/asthma below:
California legislation requires accessible epinephrine in schools
When a child has an anaphylactic reaction in school, prompt administration of epinephrine can be lifesaving. Yet autoinjectors often are kept under lock and key in the nurse’s office, and school personnel lack the training to use them. Read more.
Broad panels, IgG testing unnecessary for food intolerances, sensitivities
Food intolerances and insensitivities may involve gastrointestinal symptoms, but they are not allergic reactions, an expert said. Read more.
Early introduction of peanut, egg to infants associated with intake of other allergens
More than half of caregivers did not introduce peanut and one-third did not introduce egg to their children before age 1 year, despite guidelines to do so, according to a study published in Pediatric Allergy and Immunology. Read more.
Guide patients to quality online food allergy resources to combat misinformation
Life-impacting diagnoses often trigger intense quests for knowledge, especially for parents and caregivers, according to Tamara Hubbard, MA, LCPC. Read more.
Weight-tiered dose regimens of dupilumab may affect type 2 biomarkers
Weight-tiered dose regimens of dupilumab affected type 2 biomarkers and kept dupilumab concentrations in a therapeutic range in children with moderate to severe asthma, according to a study. Read more.